Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
side by side viewer icon HTML

Abstract

Concerning the past few years in terms of health and nature, the globe has witnessed an upsurge in the use of nutraceuticals and nutritional and natural products in therapeutics. The major reason for this step is the conventional pharmacological treatment using synthetic drugs that do not meet the status of health and therapeutic requirements for various pathological conditions. Nutraceuticals promise prominent health and therapeutic benefits with no adverse or side effects, providing extra health benefits besides their action in any defined pathological condition. Nutraceuticals are extensive biological therapies that include herbs, vitamins, fatty acids, prebiotics, and probiotics used to promote and maintain health to prevent and cure pathological conditions, malignant processes, syndromes, and symptoms. Nutraceuticals have multidirectional therapeutic benefits and are claimed to be effective products in aiding human health. The addition of omega-3 for the treatment of mental and mood disorders was found to have safer, more valuable, and better therapeutic results in comparison to the use of synthetic drugs. Omega-3 is available in the regular diet through soybeans, walnuts, codfish, and salmon fish, and its constituents have been found to play a promising role in brain development, including brain aging and neurodegenerative disorders, in the pathology of mental and mood disorders, and treatment of the same. Supplementation with Omega-3 PUFA provides a promising effect in better brain development, treatment, prevention and cure of mental and mood disorders. This review endeavours to display and assert the clinical relevance of omega-3 PUFA in brain development, pathology, and treatment of mental and mood disorders.

© 2023 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X255340231115095951
2023-01-01
2025-01-28

  • From This Site

    /content/journals/cis/10.2174/012210299X255340231115095951
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E2210299X255340.html?itemId=/content/journals/cis/10.2174/012210299X255340231115095951&mimeType=html&fmt=ahah

References

  1. ChaudhariS.P. PriyatamaV. PratapwarM.N. Nutraceuticals: A review.World J. Pharm. Pharm. Sci.20176868173910.20959/wjpps20178‑9825
     [Google Scholar]
  2. SinghJ. SinhaS. Classification, regulatory acts and applications of nutraceuticals for health: A review.Int. J. Pharm. Biol. Sci.20122177187
     [Google Scholar]
  3. MaxwellJ. Food as pharma as wellness products evolve, the distinction between food and medicine blurs.R&C Worlds Express2012https://www.pwc.com/gx/en/retail-consumer/pdf/rc-worlds-newsletter-foods-final.pdf
     [Google Scholar]
  4. KokateC.K. PurohitA.P. GokhaleS.B. Pharmacognosy.55th edIndiaNirali Prakashan2008
     [Google Scholar]
  5. LodhiS. RageebMd. UsmanMd. TusharA. DeshmukhK. VaibhavM. DarvhekarK. MohanL.K. A textbook of Herbal Drug Technology.IndiaNirali Prakashan2019
     [Google Scholar]
  6. KumarP. NirdeshK. OmerT. Nutraceuticals- critical supplement for building a healthy India.World J. Pharm. Pharm. Sci.20165579594
     [Google Scholar]
  7. OlaiyaC.O. SoetanK.O. EsanA.M. The role of nutraceuticals, functional foods and value added food products in the prevention and treatment of chronic diseases.Afr. J. Food Sci.2016101018519310.5897/AJFS2015.1402
     [Google Scholar]
  8. NamdeoS. BhaskarB. SunilD. KumbharP. Nutraceuticals: A review on current status.Research J. Pharm. and Tech20147110113
     [Google Scholar]
  9. KharbS. SinghV. Nutriceuticals in health and disease prevention.Indian J. Clin. Biochem.2004191505310.1007/BF0287238923105426
     [Google Scholar]
  10. AhadT. NissarJ. RatherA.H. Nutraceuticals health-benefits: A review.International Journal of Engineering Technology Science and Research20074262265
     [Google Scholar]
  11. KeservaniR.K. SinghSwati SinghV. KesharwaniR.K. SharmaA.K. Nutraceuticals and Functional Foods in the Prevention of Mental Disorders: A review: Nutraceuticals and Functional Foods in Human Health and Disease PreventionBagchi Debasis, Preuss Harry G., Swaroop Anand, CRC Press2016255265
     [Google Scholar]
  12. HardyG.N. FoodsF. Nutraceuticals and Functional Foods.Introduction and Meaning Nutraceutical200016718719
     [Google Scholar]
  13. KathleenC StephenD. Nutraceuticals: What Are They and Do They Work?Kentucky Equine Research, Inc. Versailles, KY20137150
     [Google Scholar]
  14. KasbiaG.S. Functional foods and nutraceuticals in the management of obesity.Nutr. Food Sci.200535534435210.1108/00346650510625557
     [Google Scholar]
  15. ThomasB. GhebremeskelK. LowyC. CrawfordM. Offley-ShoreB. Nutrient intake of women with and without gestational diabetes with a specific focus on fatty acids.Nutrition200622323023610.1016/j.nut.2005.07.01716500549
     [Google Scholar]
  16. FrydoonfarH.R. McGrathD.R. SpigelmanA.D. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin.Colorectal Dis.20035214915210.1046/j.1463‑1318.2003.00444.x12780904
     [Google Scholar]
  17. McMILLAND.C. TalwarD. SattarN. UnderwoodM. St J O’ReillyD. McARDLEC.O.L.I.N. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours.Clin. Nutr.200221216116410.1054/clnu.2001.052712056790
     [Google Scholar]
  18. 18. Prine health primary nephrology, best vitamins for kidney disease - what are they - PRINE health2002
     [Google Scholar]
  19. AnneW. AllisonG. Ross and Wilson Anatomy and Physiology in Health and IllnessNinth editionChurchill LivingstoneEdinburgh london new york oxford philadelphiast louis sydney and Toronto2001
     [Google Scholar]
  20. Anatomy of Brain, Mayfield Brain & Spine, Brain anatomy,Anatomy of the human brain | Mayfield Brain & Spine Cincinnati, Ohio (mayfieldclinic.com)
     [Google Scholar]
  21. TripathiK.D. Essential of Medical Pharmacology, Eight edition, Jaypee Brothers Medical Publishers (P) Ltd.New DelhiThe Health Services Publisher2018
     [Google Scholar]
  22. MohanH. Textbook of PathologySeventh editionJaypee Brothers Medical Publishers (P) Ltd., New Delhi201510.5005/jp/books/12412
     [Google Scholar]
  23. RoberfroidM.B. Global view on functional foods: European perspectives.Br. J. Nutr.200288S2Suppl. 2S133S13810.1079/BJN200267712495454
     [Google Scholar]
  24. MenradK. Market and marketing of functional food in Europe.J. Food Eng.2003562-318118810.1016/S0260‑8774(02)00247‑9
     [Google Scholar]
  25. KeservaniR.K. VyasN. JainS. RaghuvanshiR. SharmaA.K. Nutraceutical and functional food as future food: A review.Pharm. Lett.20102106116
     [Google Scholar]
  26. LichtensteinA.H. Thematic review series: Patient-oriented research. dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns.J. Lipid Res.20064781661166710.1194/jlr.R600019‑JLR20016738356
     [Google Scholar]
  27. ParkerG. GibsonN.A. BrotchieH. HerucG. ReesA.M. Hadzi-PavlovicD. Omega-3 fatty acids and mood disorders.Am. J. Psychiatry2006163696997810.1176/ajp.2006.163.6.96916741195
     [Google Scholar]
  28. IsabelleD. GaelleC.P. Advancing age, and brain function a review, nutraceuticals and functional foods in human health and disease preventionBagchi Debasis, Preuss Harry G., Swaroop Anand, CRC Press2016217232
     [Google Scholar]
  29. FereidoonS. PriyathariniA. Omega-3 polyunsaturated fatty acids and their health benefits.Annu. Rev. Food Sci. Technol.2016352366
     [Google Scholar]
  30. DietitC. Food Sources of Omega-3 Fats.2013https://blogs.dal.ca/nutritioncorner/files/2020/02/Omega-3.pdf
     [Google Scholar]
  31. ShahidiF. MiraliakbariH. Omega-3 (n-3) fatty acids in health and disease: Part 1--cardiovascular disease and cancer.J. Med. Food20047438740110.1089/jmf.2004.7.38715671680
     [Google Scholar]
  32. ShahidiF. MiraliakbariH. Marine oils: Compositional characteristics and health effects, nutraceutical and specialty lipids and their co-products. ShahidiF. Boca Raton, FLCRC Press2006227250
     [Google Scholar]
  33. ShahidiF. Functional seafood lipids and proteins, Functional Foods: Biochemical and Processing Aspects. MazzaG. Lancaster, UKTechnomic Publ1998381401
     [Google Scholar]
  34. HarimanaY. SamehA.K. AbdelmoneimH.A. MarieA.T. IldephonseH. SherifM. Abed, extraction, refining and purification of ω-3 pufa through different techniques – a review.American Journal of Food Science and Nutrition Research201641826
     [Google Scholar]
  35. BotineşteanC. GruiaA.T. JianuI. Utilization of seeds from tomato processing wastes as raw material for oil production.J. Mater. Cycles Waste Manag.201517111812410.1007/s10163‑014‑0231‑4
     [Google Scholar]
  36. ChantachumS. BenjakulS. SriwiratN. Separation and quality of fish oil from precooked and non-precooked tuna heads.Food Chem.200069328929410.1016/S0308‑8146(99)00266‑6
     [Google Scholar]
  37. LinderM. FanniJ. ParmentierM. Proteolytic extraction of salmon oil and PUFA concentration by lipases.Mar. Biotechnol.200571707610.1007/s10126‑004‑0149‑215759086
     [Google Scholar]
  38. RolleR.S. Review: Enzyme applications for agro-processing in developing countries: An inventory of current and potential applications.World J. Microbiol. Biotechnol.199814561161910.1023/A:1008896500986
     [Google Scholar]
  39. CvengrosJ. Physical refining of edible oils.J. Am. Oil Chem. Soc.199572101193119610.1007/BF02540987
     [Google Scholar]
  40. AdlofR.O. EmkenE.A. The isolation of omega‐3 polyunsaturated fatty acids and methyl esters of fish oils by silver resin chromatography.J. Am. Oil Chem. Soc.198562111592159510.1007/BF02541694
     [Google Scholar]
  41. SenanayakeS.P.J.N. ShahidiF. Concentration of docosahexaenoic acid (DHA) from algal oil via urea complexation.J. Food Lipids200071516110.1111/j.1745‑4522.2000.tb00160.x
     [Google Scholar]
  42. HayesD.G. Van AlstineJ.M. SetterwallF. Urea‐based fractionation of seed oil samples containing fatty acids and acylglycerols of polyunsaturated and hydroxy fatty acids.J. Am. Oil Chem. Soc.200077220721310.1007/s11746‑000‑0033‑5
     [Google Scholar]
  43. HwangL.S. LiangJ.H. Fractionation of urea‐pretreated squid visceral oil ethyl esters.J. Am. Oil Chem. Soc.200178547347610.1007/s11746‑001‑0288‑x
     [Google Scholar]
  44. HayashiK. KishimuraH. Preparation of n-3 PUFA ethyl-ester concentrates from fish-oil by column chromatography on silicic-acid.Nippon Suisan Gakkaishi1993598142910.2331/suisan.59.1429
     [Google Scholar]
  45. BousquetO. Le GofficF. Counter-current chromatographic separation of polyunsaturated fatty acids.J. Chromatogr. A1995704121121610.1016/0021‑9673(94)01233‑5
     [Google Scholar]
  46. MozaffarianD. WuJ.H.Y. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.J. Am. Coll. Cardiol.201158202047206710.1016/j.jacc.2011.06.06322051327
     [Google Scholar]
  47. PatelJ. PatelA.S. The Role of Nutritional Factors in Pathogenesis of Diseases, Nutrigenomics and Nutraceuticals Clinical Relevance and Disease Prevention.Yashwant V. Pathak Ali M. Ardekani. CRC Press2018483505
     [Google Scholar]
  48. ShiY. BurnP. Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity.Nat. Rev. Drug Discov.20043869571010.1038/nrd146915286736
     [Google Scholar]
  49. BeckermannB. BenekeM. SeitzI. [Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers].Arzneimittelforschung19904067007042144420
     [Google Scholar]
  50. AilhaudG. MassieraF. WeillP. LegrandP. AlessandriJ. GuesnetP. Temporal changes in dietary fats: Role of n−6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity.Prog. Lipid Res.200645320323610.1016/j.plipres.2006.01.00316516300
     [Google Scholar]
  51. Champeil-PotokarG. DenisI. Goustard-LangelierB. AlessandriJ.M. GuesnetP. LavialleM. Astrocytes in culture require docosahexaenoic acid to restore the n‐3/n‐6 polyunsaturated fatty acid balance in their membrane phospholipids.J. Neurosci. Res.20047519610610.1002/jnr.1081714689452
     [Google Scholar]
  52. CunnaneS.C. FrancescuttiV. BrennaJ.T. CrawfordM.A. Breast‐fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula‐fed infants not consuming dietary docosahexaenoate.Lipids200035110511110.1007/s11745‑000‑0501‑610695931
     [Google Scholar]
  53. StillwellW. WassallS.R. Docosahexaenoic acid: Membrane properties of a unique fatty acid.Chem. Phys. Lipids2003126112710.1016/S0009‑3084(03)00101‑414580707
     [Google Scholar]
  54. FedorovaI. SalemN.Jr Omega-3 fatty acids and rodent behavior.Prostaglandins Leukot. Essent. Fatty Acids2006754-527128910.1016/j.plefa.2006.07.00616973342
     [Google Scholar]
  55. NedergaardM. VerkhratskyA. Artifact versus reality-How astrocytes contribute to synaptic events.Glia20126071013102310.1002/glia.2228822228580
     [Google Scholar]
  56. McCannJ.C. AmesB.N. Is docosahexaenoic acid, an n−3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals.Am. J. Clin. Nutr.200582228129510.1093/ajcn/82.2.28116087970
     [Google Scholar]
  57. MatuteC. DomercqM. Sánchez-GómezM.V. Glutamate‐mediated glial injury: Mechanisms and clinical importance.Glia200653221222410.1002/glia.2027516206168
     [Google Scholar]
  58. CotrinaM.L. NedergaardM. Astrocytes in the aging brain.J. Neurosci. Res.200267111010.1002/jnr.1012111754075
     [Google Scholar]
  59. DyallS.C. MichaelG.J. WhelptonR. ScottA.G. Michael-TitusA.T. Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain.Neurobiol. Aging200728342443910.1016/j.neurobiolaging.2006.01.00216500747
     [Google Scholar]
  60. FarooquiA.A. HorrocksL.A. FarooquiT. Modulation of inflammation in brain: A matter of fat.J. Neurochem.2007101357759910.1111/j.1471‑4159.2006.04371.x17257165
     [Google Scholar]
  61. YiJ.H. HazellA.S. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.Neurochem. Int.200648539440310.1016/j.neuint.2005.12.00116473439
     [Google Scholar]
  62. SheldonA.L. RobinsonM.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.Neurochem. Int.2007516-733335510.1016/j.neuint.2007.03.01217517448
     [Google Scholar]
  63. GrintalB. Champeil-PotokarG. LavialleM. VancasselS. BretonS. DenisI. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: Evidence for a signalling role of docosahexaenoic acid.Neurochem. Int.200954853554310.1016/j.neuint.2009.02.01819428799
     [Google Scholar]
  64. LongE.K. RosenbergerT.A. PickloM.J.Sr Ethanol withdrawal increases glutathione adducts of 4-hydroxy-2-hexenal but not 4-hydroxyl-2-nonenal in the rat cerebral cortex.Free Radic. Biol. Med.201048338439010.1016/j.freeradbiomed.2009.10.04819878718
     [Google Scholar]
  65. HaydonP.G. CarmignotoG. Astrocyte control of synaptic transmission and neurovascular coupling.Physiol. Rev.20068631009103110.1152/physrev.00049.200516816144
     [Google Scholar]
  66. CalderP.C. Omega‐3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?Br. J. Clin. Pharmacol.201375364566210.1111/j.1365‑2125.2012.04374.x22765297
     [Google Scholar]
  67. CalderP.C. Fatty acids and inflammation: The cutting edge between food and pharma.Eur. J. Pharmacol.2011668Suppl. 1S50S5810.1016/j.ejphar.2011.05.08521816146
     [Google Scholar]
  68. OrrS.K. PalumboS. BosettiF. MountH.T. KangJ.X. GreenwoodC.E. MaD.W.L. SerhanC.N. BazinetR.P. Unesterified docosahexaenoic acid is protective in neuroinflammation.J. Neurochem.2013127337839310.1111/jnc.1239223919613
     [Google Scholar]
  69. ChangC.L. DeckelbaumR.J. Omega-3 fatty acids.Curr. Opin. Lipidol.201324434535010.1097/MOL.0b013e328361636423594712
     [Google Scholar]
  70. MusiekE.S. BrooksJ.D. JooM. BrunoldiE. PortaA. ZanoniG. VidariG. BlackwellT.S. MontineT.J. MilneG.L. McLaughlinB. MorrowJ.D. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid.J. Biol. Chem.200828329199271993510.1074/jbc.M80362520018490445
     [Google Scholar]
  71. EckertG.P. LipkaU. MullerW.E. Omega-3 fatty acids in neurodegenerative diseases: Focus on mitochondria.Prostaglandins Leukot. Essent. Fatty Acids201388110511410.1016/j.plefa.2012.05.00622727983
     [Google Scholar]
  72. DenisI. PotierB. HeberdenC. VancasselS. ω-3 polyunsaturated fatty acids and brain aging.Curr. Opin. Clin. Nutr. Metab. Care201518213914610.1097/MCO.000000000000014125501348
     [Google Scholar]
  73. HaastR.A.M. KiliaanA.J. Impact of fatty acids on brain circulation, structure and function.Prostaglandins Leukot. Essent. Fatty Acids20159231410.1016/j.plefa.2014.01.00224485516
     [Google Scholar]
  74. Ximenes da SilvaA. LavialleF. GendrotG. GuesnetP. AlessandriJ.M. LavialleM. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids.J. Neurochem.20028161328133710.1046/j.1471‑4159.2002.00932.x12068080
     [Google Scholar]
  75. PifferiF. RouxF. LangelierB. AlessandriJ.M. VancasselS. JouinM. LavialleM. GuesnetP. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats.J. Nutr.200513592241224610.1093/jn/135.9.224116140905
     [Google Scholar]
  76. CunnaneS.C. PlourdeM. PifferiF. BéginM. FéartC. Barberger-GateauP. Fish, docosahexaenoic acid and Alzheimer’s disease.Prog. Lipid Res.200948523925610.1016/j.plipres.2009.04.00119362576
     [Google Scholar]
  77. BennettD.A. ArnoldS.E. ValenzuelaM.J. BrayneC. SchneiderJ.A. Cognitive and social lifestyle: Links with neuropathology and cognition in late life.Acta Neuropathol.2014127113715010.1007/s00401‑013‑1226‑224356982
     [Google Scholar]
  78. TitovaO.E. SjögrenP. BrooksS.J. KullbergJ. AxE. KilanderL. RiserusU. CederholmT. LarssonE.M. JohanssonL. AhlströmH. LindL. SchiöthH.B. BenedictC. Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly.Age20133541495150510.1007/s11357‑012‑9453‑322791395
     [Google Scholar]
  79. MazereeuwG. LanctôtK.L. ChauS.A. SwardfagerW. HerrmannN. Effects of ω-3 fatty acids on cognitive performance: A meta-analysis.Neurobiol. Aging20123371482.e171482.e2910.1016/j.neurobiolaging.2011.12.01422305186
     [Google Scholar]
  80. Barberger-GateauP. LetenneurL. DeschampsV. PérèsK. DartiguesJ.F. RenaudS. Fish, meat, and risk of dementia: Cohort study.BMJ2002325737093293310.1136/bmj.325.7370.93212399342
     [Google Scholar]
  81. MischoulonD. FavaM. Docosahexanoic acid and ω-3 fatty acids in depression.Psychiatr. Clin. North Am.200023478579410.1016/S0193‑953X(05)70197‑011147247
     [Google Scholar]
  82. BlockE.R. EdwardsD. Effect of plasma membrane fluidity on serotonin transport by endothelial cells.Am. J. Physiol. Cell Physiol.19872535C672C67810.1152/ajpcell.1987.253.5.C6723688215
     [Google Scholar]
  83. HibbelnJ.R. Fish consumption and major depression.Lancet19983519110121310.1016/S0140‑6736(05)79168‑69643729
     [Google Scholar]
  84. YehudaS. RabinovitzS. MostofskyD.I. Essential fatty acids and the brain: From infancy to aging.Neurobiol. Aging20052619810210.1016/j.neurobiolaging.2005.09.01316226347
     [Google Scholar]
  85. Dijck-BrouwerD.A.J. Hadders-AlgraM. BouwstraH. DecsiT. BoehmG. MartiniI.A. BoersmaE.R. MuskietF.A.J. Lower fetal status of docosahexaenoic acid, arachidonic acid and essential fatty acids is associated with less favorable neonatal neurological condition.Prostaglandins Leukot. Essent. Fatty Acids2005721212810.1016/j.plefa.2004.08.00215589396
     [Google Scholar]
  86. MathaiM.L. SoueidM. ChenN. JayasooriyaA.P. SinclairA.J. WlodekM.E. WeisingerH.S. WeisingerR.S. Does perinatal ω-3 polyunsaturated fatty acid deficiency increase appetite signaling?Obes. Res.200412111886189410.1038/oby.2004.23415601986
     [Google Scholar]
  87. FarooquiA.A. HorrocksL.A. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.J. Mol. Neurosci.2001162-326327210.1385/JMN:16:2‑3:26311478381
     [Google Scholar]
  88. KeservaniR.K. KesharwaniR.K. SharmaA.K. AhmadM. FasihM. Stress, Parkinson’s, and Alzheimer’s Disease Role of Dietary Supplements, Nutraceuticals and Functional Foods in Human Health and Disease PreventionBagchi Debasis, Preuss Harry G., Swaroop Anand, CRC Press2016241251
     [Google Scholar]
  89. SeshadriS. BeiserA. SelhubJ. JacquesP.F. RosenbergI.H. D’AgostinoR.B. WilsonP.W.F. WolfP.A. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease.N. Engl. J. Med.2002346747648310.1056/NEJMoa01161311844848
     [Google Scholar]
  90. KalmijnS. FeskensE.J.M. LaunerL.J. KromhoutD. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men.Am. J. Epidemiol.19971451334110.1093/oxfordjournals.aje.a0090298982020
     [Google Scholar]
  91. ConquerJ.A. TierneyM.C. ZecevicJ. BettgerW.J. FisherR.H. Fatty acid analysis of blood plasma of patients with alzheimer’s disease, other types of dementia, and cognitive impairment.Lipids200035121305131210.1007/s11745‑000‑0646‑311201991
     [Google Scholar]
  92. SwansonD. BlockR. MousaS.A. Omega-3 fatty acids EPA and DHA: Health benefits throughout life.Adv. Nutr.2012311710.3945/an.111.00089322332096
     [Google Scholar]
  93. KeservaniR.K. KesharwaniR.K. SharmaA.K. VyasN. ChadokerA. Nutritional supplements: An overview.Int. J. Curr. Pharm Rev. Res.201015975
     [Google Scholar]
  94. ChenH. TappelA.L. Vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, beta-carotene, canthaxanthin, and (+)-catechin protect against oxidative damage to kidney, heart, lung and spleen.Free Radic. Res.199522217718610.3109/107157695091475377704186
     [Google Scholar]
  95. NagamatsuM. NickanderK.K. SchmelzerJ.D. RayaA. WittrockD.A. TritschlerH. LowP.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.Diabetes Care19951881160116710.2337/diacare.18.8.11607587852
     [Google Scholar]
  96. PandyaC.D. HowellK.R. PillaiA. Antioxidants as potential therapeutics for neuropsychiatric disorders.Prog. Neuropsychopharmacol. Biol. Psychiatry20134621422310.1016/j.pnpbp.2012.10.01723123357
     [Google Scholar]
  97. KhajehnasiriF. MortazaviS.B. AllamehA. AkhondzadehS. Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: A randomized double-blind placebo-controlled study.J. Clin. Biochem. Nutr.2013531364010.3164/jcbn.12‑9823874068
     [Google Scholar]
  98. Skulas-RayA.C. WilsonP.W.F. HarrisW.S. BrintonE.A. Kris-EthertonP.M. RichterC.K. JacobsonT.A. EnglerM.B. MillerM. RobinsonJ.G. BlumC.B. Rodriguez-LeyvaD. de FerrantiS.D. WeltyF.K. Omega-3 Fatty Acids for the Management of HypertriglyceridemiaA Science Advisory From the American Heart Association. Circulation201914012e673e69110.1161/CIR.000000000000070931422671
     [Google Scholar]
  99. BrintonE.A. MasonR.P. Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA).Lipids Health Dis.20171612310.1186/s12944‑017‑0415‑828137294
     [Google Scholar]
  100. FabianC.J. KimlerB.F. HurstingS.D. Omega-3 fatty acids for breast cancer prevention and survivorship.Breast Cancer Res.20151716210.1186/s13058‑015‑0571‑625936773
     [Google Scholar]
  101. FialkowJ. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.Am. J. Cardiovasc. Drugs201616422923910.1007/s40256‑016‑0170‑727138439
     [Google Scholar]
  102. ItoMK A Comparative Overview of Prescription Omega-3 Fatty Acid Products.P T. journal20154012826857
     [Google Scholar]
  103. NabaviS.F. BilottoS. RussoG.L. OrhanI.E. HabtemariamS. DagliaM. DeviK.P. LoizzoM.R. TundisR. NabaviS.M. Omega-3 polyunsaturated fatty acids and cancer: Lessons learned from clinical trials.Cancer Metastasis Rev.201534335938010.1007/s10555‑015‑9572‑226227583
     [Google Scholar]
  104. SacconeG. BerghellaV. Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: A systematic review and meta-analysis.Obstet. Gynecol.2015125366367210.1097/AOG.000000000000066825730231
     [Google Scholar]
  105. García-HernándezJ. Ortega-VélezM.I. Contreras-PaniaguaA.D. Aguilera-MárquezD. Leyva-GarcíaG. TorreJ. Mercury concentrations in seafood and the associated risk in women with high fish consumption from coastal villages of Sonora, Mexico.Food Chem. Toxicol.201812036737710.1016/j.fct.2018.07.02930026089
     [Google Scholar]
  106. Is excessive consumption of omega-3 fatty acids bad for you?Available From: https://www.ndtv.com/health/is-excessive-consumption-of-omega-3-fatty-acids-bad-for-you-1936803 (Accessed on 14 September 2023).
  107. IndiamartAvailable From: https://dir.indiamart.com/search.mp?ss=omega3+&prdsrc=1&mcatid=203861&catid=578&stype=attr=1
  108. Amway, NutriliteAvailable From: https://www.amway.in/amway-brands/nutrilite
/content/journals/cis/10.2174/012210299X255340231115095951
Loading
Role of Omega-3PUFA: A Nutraceutical for Brain Functioning and Treatment of Mental Disorders
Curr. Indian Sci. 1, E2210299X255340 (2023); https://doi.org/10.2174/012210299X255340231115095951
/content/journals/cis/10.2174/012210299X255340231115095951
/content/journals/cis/10.2174/012210299X255340231115095951
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Brain; Brain aging; Mental and mood disorders; Neurodegenerative; Nutraceuticals; Omega-3 PUFA

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test